Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (öffnet neues Fenster)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Quelle‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

Indiziert‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (öffnet neues Fenster)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (öffnet neues Fenster)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Quelle‎: Lancet 2018;391(10116):125-32.

Indiziert‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (öffnet neues Fenster)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (öffnet neues Fenster)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Quelle‎: Am J Perinatol 2013;30(5):407-13.

Indiziert‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (öffnet neues Fenster)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (öffnet neues Fenster)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Quelle‎: Am J Perinatol 2011;28(3):233-40.

Indiziert‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (öffnet neues Fenster)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (öffnet neues Fenster)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Quelle‎: Lancet 2017;389(10084):2105-16.

Indiziert‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (öffnet neues Fenster)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (öffnet neues Fenster)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Quelle‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Indiziert‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (öffnet neues Fenster)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (öffnet neues Fenster)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Quelle‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Indiziert‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (öffnet neues Fenster)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (öffnet neues Fenster)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Quelle‎: Obstet Gynecol 2007;110(6):1270-8.

Indiziert‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (öffnet neues Fenster)

The use of recombinant activated FVII in postpartum hemorrhage. (öffnet neues Fenster)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Quelle‎: Clin Obstet Gynecol 2010;53(1):219-27.

Indiziert‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (öffnet neues Fenster)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (öffnet neues Fenster)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Quelle‎: J Perinat Med 2011;40(1):43-9.

Indiziert‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (öffnet neues Fenster)

Postpartum hemorrhage: when uterotonics and sutures fail. (öffnet neues Fenster)

James AH, McLintock C, Lockhart E.

Quelle‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Indiziert‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (öffnet neues Fenster)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (öffnet neues Fenster)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Quelle‎: Int J Hematol 2012;95(1):57-63.

Indiziert‎: PubMed 22160834

DOI‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (öffnet neues Fenster)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (öffnet neues Fenster)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Quelle‎: J Thromb Haemost 2015;13(4):520-9.

Indiziert‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (öffnet neues Fenster)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (öffnet neues Fenster)

Lim Y, Loo CC, Chia V, Fun W.

Quelle‎: Int J Gynaecol Obstet 2004;87(2):178-9.

Indiziert‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (öffnet neues Fenster)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (öffnet neues Fenster)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Quelle‎: Br J Haematol 2001;114(1):174-6.

Indiziert‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (öffnet neues Fenster)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (öffnet neues Fenster)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Quelle‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

Indiziert‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (öffnet neues Fenster)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (öffnet neues Fenster)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Quelle‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Indiziert‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (öffnet neues Fenster)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (öffnet neues Fenster)

Pepas LP, Arif-Adib M, Kadir RA.

Quelle‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Indiziert‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (öffnet neues Fenster)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (öffnet neues Fenster)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Quelle‎: Anesth Analg 2009;109(6):1908-15.

Indiziert‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (öffnet neues Fenster)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (öffnet neues Fenster)

Prosper SC, Goudge CS, Lupo VR.

Quelle‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

Indiziert‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (öffnet neues Fenster)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (öffnet neues Fenster)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Quelle‎: Transfus Med 2012;22(5):344-9.

Indiziert‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (öffnet neues Fenster)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (öffnet neues Fenster)

Bell SF, Rayment R, Collins PW, Collis RE.

Quelle‎: Int J Obstet Anesth 2010;19(2):218-23.

Indiziert‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (öffnet neues Fenster)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (öffnet neues Fenster)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Quelle‎: Br J Anaesth 2012;108(6):984-9.

Indiziert‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (öffnet neues Fenster)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (öffnet neues Fenster)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Quelle‎: J Nippon Med Sch 2014;81(2):94-6.

Indiziert‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (öffnet neues Fenster)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (öffnet neues Fenster)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Quelle‎: Haemophilia 2012;18(1):25-33.

Indiziert‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (öffnet neues Fenster)

Tisseel for management of traumatic postpartum haemorrhage. (öffnet neues Fenster)

Dhulkotia JS, Alazzam M, Galimberti A.

Quelle‎: Arch Gynecol Obstet 2009;279(3):437-9.

Indiziert‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (öffnet neues Fenster)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (öffnet neues Fenster)

Moriarty KT, Premila S, Bulmer PJ.

Quelle‎: BJOG 2008;115(6):793-5.

Indiziert‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (öffnet neues Fenster)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (öffnet neues Fenster)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Quelle‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Indiziert‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (öffnet neues Fenster)

Fibrin sealant for management of complicated obstetric lacerations. (öffnet neues Fenster)

Whiteside JL, Asif RB, Novello RJ.

Quelle‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Indiziert‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (öffnet neues Fenster)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (öffnet neues Fenster)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Quelle‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

Indiziert‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (öffnet neues Fenster)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (öffnet neues Fenster)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Quelle‎: Int J Obstet Anesth 2011;20(4):293-8.

Indiziert‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (öffnet neues Fenster)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (öffnet neues Fenster)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Quelle‎: Obstet Gynecol Surv 2012;67(7):426-35.

Indiziert‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (öffnet neues Fenster)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (öffnet neues Fenster)

Karlsson O, Jeppsson A, Hellgren M.

Quelle‎: Int J Obstet Anesth 2014;23(1):10-7.

Indiziert‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (öffnet neues Fenster)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (öffnet neues Fenster)

Levy JH, Welsby I, Goodnough LT.

Quelle‎: Transfusion 2014;54(5):1389-405.

Indiziert‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (öffnet neues Fenster)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (öffnet neues Fenster)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Quelle‎: Int J Obstet Anesth 2015;24(2):174-9.

Indiziert‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (öffnet neues Fenster)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (öffnet neues Fenster)

Solomon C, Collis RE, Collins PW.

Quelle‎: Br J Anaesth 2012;109(6):851-63.

Indiziert‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (öffnet neues Fenster)